Neuroimaging – News and Features

With a new neural network model, researchers have a better tool to uncover what brain mechanisms are at play when people need to focus amid many distractions.

Researchers have discovered that stomach cancers make electrical connections with nearby sensory nerves and use these malignant circuits to stimulate the cancer’s growth and spread.

A research team has identified changes in brain rhythms that indicate seizure activity in Alzheimer’s patients.

Researchers found that COVID-19 is linked to increased biomarkers associated with Alzheimer’s disease, particularly in those hospitalized or with risk factors like high blood pressure.

A new study finds that oral ketamine significantly reduces PTSD symptoms, with 73% of participants seeing a 50% reduction in symptoms. The treatment, taken as a liquid drink, was well-tolerated and had fewer side effects than intravenous ketamine.

Five years after SARS-CoV-2 first surfaced in Wuhan, China, researchers are still trying to understand long COVID. In this article, discover the latest research investigating the lasting impact of the virus on brain function.

A study of over 1,000 young adults reveals that heavy cannabis use reduces brain activity in key areas associated with working memory, including the prefrontal cortex. Both recent and lifetime use showed significant impacts on cognition.

A study reveals brain biomarkers PAF and CME can predict pain sensitivity and chronic pain risk with 88% accuracy. The findings could enable personalized treatment and prevent transitions from acute to chronic pain.

A study identifies the P2X7 receptor as a driver of post-traumatic epilepsy (PTE) following brain injuries. Blocking the receptor reduced brain hyperexcitability and damage in models.

Researchers have developed a new electrically active biomaterial that can be transplanted into the body to improve recovery following central nervous system injuries. The material acts as a scaffold that also provides electrical stimulation.